Clinical trial
Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
NCT00311662 · Minster Research Ltd, Industry · Completed
Key facts
| NCT number | NCT00311662 |
|---|---|
| Title | Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache |
| Official title | Multi-centre, Parallel Group, Double-blind, Placebo Controlled Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache |
| Lead sponsor | Minster Research Ltd, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine Without Aura, Migraine With Aura |
| Intervention type | Drug |
| Interventions | Tonabersat, Placebo |
| Enrollment | 124 |
| Start date | Apr 1, 2006 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Apr 6, 2006 |
| Last update posted | Aug 31, 2009 |
| Countries | Denmark, Hungary, South Africa, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: